0.5ml

Menveo

Menveo Powder and Solution for Injection

Meningococcal

Novartis Pharmaceuticals (Pvt) Ltd.

Drug Identity

Active Ingredient
Meningococcal
Drug Class
Vaccine
Chemical Class
Toxoids and Vaccines pharmacological group
0

What is Menveo?

Uses
Meningitis Vaccine is a sterile lyophilized extract of the group specified polysaccharide capsular antigens from Neisseria meningitidis. ...

How It Works

Chemical Class
Toxoids and Vaccines pharmacological group

It belongs to Toxoids and Vaccines pharmacological group.

How to Take It

1
Adult · SC
0.5 ml — As recommended.
Same dose for children above 2 months of age and Adults.
2
Child · Subcutaneous
0.5 ml — As recommended.
For once, or as required

Safety Alerts

Meningitis Vaccine is contraindicated in conditions like Hypersensitivity to any component of product

Important Warnings

Pregnancy, lactation

Side Effects

Low grade feverpain at inj siteRare: Kawasaki disease (in children)unusual crying (in children)

Drug Interactions

Immuno-suppressants.

Storage

Inj Store in refrigerator. Do not Freeze. Protect from Sunlight.

Price Intelligence

Rs 5,488.95
DRAP approved maximum price · per unit · approved 23 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper unitRs 5,488.95

Should you consider an alternative?

Other options containing Meningococcal, and what they are not.

These contain this ingredient plus others. They are different medicines — do not swap.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.